Clinical Profile Among Brazilian Mucopolysaccharidosis type II Patients: Subgroup Analysis from the Hunter Outcome Survey

Abstract Mucopolysaccharidosis type II (MPS II) is a rare genetic, multiorgan disease. Little information about the Brazilian context is available to date; thus, this descriptive subgroup analysis was conducted on Brazilian data from the Hunter Outcome Survey (HOS), including clinical characteristic...

Full description

Bibliographic Details
Published in:	Journal of Inborn Errors of Metabolism and Screening
Main Authors:	Dafne D G Horovitz, Márcia G Ribeiro, Angelina X Acosta, Ana C Monteiro, Jaco Botha, Roberto Giugliani
Format:	Article
Language:	English
Published:	SciELO 2023-09-01
Subjects:	Mucopolysaccharidosis II Lysosomal Storage Diseases Survival Signs and Symptom
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2326-45942023000100304&tlng=en

Similar Items

Diagnosis and Management of Mucopolysaccharidosis Type II (Hunter Syndrome) in Poland
by: Zbigniew Żuber, et al.
Published: (2023-06-01)

Unmet needs of adults living with mucopolysaccharidosis II: data from the Hunter Outcome Survey
by: Joseph Muenzer, et al.
Published: (2025-07-01)

Identification of 17 novel mutations in 40 Argentinean unrelated families with mucopolysaccharidosis type II (Hunter syndrome)
by: H. Amartino, et al.
Published: (2014-01-01)

Clinical, Biochemical and Molecular Characteristics of Fifteen Patients with Mucopolysaccharidosis Type II in Western Turkey
by: Havva Yazıcı, et al.
Published: (2018-03-01)

Proteomic Analysis of Mucopolysaccharidosis IIIB Mouse Brain
by: Valeria De Pasquale, et al.
Published: (2020-02-01)

A Systematic Literature Review on the Global Status of Newborn Screening for Mucopolysaccharidosis II
by: Olulade Ayodele, et al.
Published: (2024-10-01)

Clinical characteristics and somatic burden of patients with mucopolysaccharidosis II with or without neurological involvement: An analysis from the Hunter Outcome Survey
by: Heather Lau, et al.
Published: (2023-12-01)

Mucopolysaccharidosis type II: Enzyme Replacement Therapy Efficiency
by: Nato D. Vashakmadze, et al.
Published: (2020-02-01)

Novel Phenotypic Insights into the <i>IDS</i> c.817C>T Variant in Mucopolysaccharidosis Type II from Newborn Screening Cohorts
by: Éliane Beauregard-Lacroix, et al.
Published: (2025-08-01)

Comprehensive Characterization of a Cluster of Mucopolysaccharidosis IIIB in Ecuador
by: María Lucía Castro Moreira, et al.
Published: (2025-09-01)

Determination of genotypic and clinical characteristics of Colombian patients with mucopolysaccharidosis IVA
by: Tapiero-Rodriguez SM, et al.
Published: (2018-04-01)

Mucopolysaccharidosis: What Pediatric Rheumatologists and Orthopedics Need to Know
by: Stefania Costi, et al.
Published: (2022-12-01)

Mucopolysaccharidosis Type-II with Pathognomonic Skin Appearance: A Case with Pebbling Sign
by: Ayşe Hitay İnan, et al.
Published: (2021-06-01)

Mucopolysachharidosis-II: A Rare Case Report
by: Kalgi Baxi, et al.
Published: (2020-10-01)

Mucopolysachharidosis-II: A Rare Case Report
by: Kalgi Baxi, et al.
Published: (2020-10-01)

Investigating the neurobehavioral symptoms of neuronopathic Hunter syndrome
by: Nathan Grant
Published: (2020-03-01)

Non-Neuropathic Form of Mucopolysaccharidosis Type II: Clinical Cases
by: Nato D. Vashakmadze, et al.
Published: (2021-03-01)

Molecular basis of mucopolysaccharidosis type II (Hunter syndrome): first review and classification of published IDS gene variants
by: Alessandra Zanetti, et al.
Published: (2024-12-01)

Recovery of Vision following Enzyme Replacement Therapy in a Patient with Mucopolysaccharidosis Type II, Hunter Syndrome
by: Ryutaro Yamanishi, et al.
Published: (2019-06-01)

Assessment of functional capacity of teens who are Mucopolysaccharidosis type II carriers
by: Ingrid Alves Barros Silva Amaral, et al.
Published: (2017-06-01)

Roentgenographic diagnosis of mucopolysaccharidosis with particular reference to Morquio syndrome
by: umesh chandra parashari, et al.
Published: (2012-02-01)

Enzyme Replacement Therapy with Idursulfase in Patients with Mucopolysaccharidosis Type II: Literature Review
by: Nato D. Vashakmadze, et al.
Published: (2021-12-01)

Mucopolysaccharidosis type IVA in children: Clinical cases
by: A. V. Burlutskaya, et al.
Published: (2022-02-01)

Newborn Screening for Mucopolysaccharidosis Type II in Illinois: An Update
by: Barbara K. Burton, et al.
Published: (2020-09-01)

Neurocognitive testing in a murine model of mucopolysaccharidosis type IIIA
by: Kleopatra Pericleous, et al.
Published: (2023-09-01)

Neuroradiological Characteristics in Patients with Mucopolysaccharidosis Type II: A Systematic Review
by: Yancarlos Ramos-Villegas, et al.
Published: (2023-02-01)

Dose-dependent effects of a brain-penetrating iduronate-2-sulfatase on neurobehavioral impairments in mucopolysaccharidosis II mice
by: Hideto Morimoto, et al.
Published: (2022-06-01)

Typical imaging features in hunter’s syndrome
by: L De Cocker Jr, et al.
Published: (2010-03-01)

Chondroitin sulfate disaccharide is a specific and sensitive biomarker for mucopolysaccharidosis type IVA
by: Sharon J. Chin, et al.
Published: (2020-09-01)

Manifestaciones bucales de pacientes con mucopolisacaridosis// Oral manifestations in patients with mucopolysaccharidosis
by: Andrea Veronica Rios
Published: (2021-01-01)

Mucopolysaccharidosis type II (Hunter syndrome) in a boy from the Republic of Serbia: A case report
by: Tubić-Vukajlović Jovana M., et al.
Published: (2023-01-01)

Avaliação prospectiva de 11 pacientes brasileiros com mucopolissacaridose II Prospective study of 11 Brazilian patients with mucopolysaccharidosis II
by: Louise L. C. Pinto, et al.
Published: (2006-08-01)

Study on the disease burden of patients with mucopolysaccharidosis type II in China
by: Ni Yuan, et al.
Published: (2024-11-01)

Levels of glycosaminoglycans in the cerebrospinal fluid of healthy young adults, surrogate-normal children, and Hunter syndrome patients with and without cognitive impairment
by: Christian J. Hendriksz, et al.
Published: (2015-12-01)

Enzymatic testing for mucopolysaccharidosis type I in Kuwaiti newborns: a preliminary study toward newborn screening
by: Hind Alsharhan, et al.
Published: (2024-07-01)

Characterization of early markers of disease in the mouse model of mucopolysaccharidosis IIIB
by: Katherine B. McCullough, et al.
Published: (2024-04-01)

Direct gene transfer to the CNS prevents emergence of neurologic disease in a murine model of mucopolysaccharidosis type I
by: Daniel A. Wolf, et al.
Published: (2011-07-01)

Importance of Long-Term Follow-Up in the Prognosis of Mucopolysaccharidosis IV-A: A Case Report from Southwestern of Colombia
by: Mariana Ardila Marín, et al.
Published: (2025-06-01)

Common N-acetylgalactosamine-6-sulfate sulfatase (GALNS) exon mutations in Brazilian patients with mucopolysaccharidosis IVA (MPS IVA)
by: Tatiana Dieter, et al.
Published: (2007-01-01)

Prenatal diagnosis of mucopolysaccharidosis type I on hepatosplenomegaly and coarse features: a case-report
by: Maxime Agranier, et al.
Published: (2025-01-01)